Boston Scientific (BSX) Device Succeeds in Over 93% of Patients in Its Pivotal Trial

Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to buy right now. On May 19, TD Cowen reiterated its Buy rating and $80 price target on Boston Scientific Corporation (NYSE:BSX).

Boston Scientific (BSX) Device Succeeds in Over 93% of Patients in Its Pivotal Trial

Image: Courtesy of Boston Scientific

TD Cowen constructed its thesis around Boston Scientific’s Fracture IDE study. The study tested the company’s SEISMIQ 4CE Coronary Intravascular Lithotripsy (IVL) Catheter, which is designed to treat severely calcified coronary artery disease (CAD). It uses laser energy inside a balloon catheter to generate acoustic pressure waves that fracture calcium deposits, preparing the vessel for stent implantation.

The IDE trial was about testing the device to see if it solves the problem of a poorly expanded stent when removing built up hard calcium deposits in arteries. Boston Scientific said in a press release that the trial proved the safety of the SEISMIQ 4CE. Also, the procedure was a success in over 93% of patients, which means the company proved the device’s effectiveness.

TD Cowen had anticipated positive results from the IDE trial. Particularly, the firm characterized the coronary IVL market as offering double-digit growth and projected it will become a $1.5 billion market in the near term. The firm noted that Boston Scientific’s SEISMIQ 4CE device targets a first-half 2027 US launch if the regulatory process proceeds as planned.

Boston Scientific Corporation (NYSE:BSX) is a medical technology company that develops and manufactures minimally invasive medical devices used in interventional cardiology, electrophysiology, endoscopy, urology, and neuromodulation. Its product portfolio includes coronary stents, cardiac rhythm management devices, ablation systems for treating heart arrhythmias, and advanced endoscopy tools used in diagnostic and therapeutic procedures.

While we acknowledge the risk and potential of BSX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BSX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 7 Best Augmented Reality Penny Stocks to Buy and 10 Best Gene Therapy Stocks to Buy in 2026.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1